The invention discloses an anti-restenotic drug to be delivered from a stent loaded with a predetermined amount of the anti-restenotic drug for use in a method of reducing restenosis, the method comprising implanting the stent having no more than the predetermined amount of the anti-restenotic drug and delivering the anti-restenotic drug from a bioresorbable polymer matrix reservoir in the stent, wherein the polymer matrix is completely resorbed between 30 days and 90 days, inclusive, and the entire predetermined amount elutes from the stent before the polymer matrix is resorbed.
